Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

High prevalence of Fall Risk–Increasing Drugs in older adults after falls

Background: Falls are the leading cause of unintentional injuries and injury-related deaths among adults aged 65 years and older. FRIDs (such as antidepressants, sedatives-hypnotics, and opioids) continue to be a major contributor for risk of falls. At the same time, little is known about prevalence of use or interventions directed toward reduction of use in older adults presenting with fall.

Dr. Yarra Pradeep, division of hospital medicine, UK HealthCare, Lexington, Ky.

Dr. Yarra Pradeep


Study design: Systematic review.

Setting: PubMed and Embase databases were used to search for studies published in English on or before June 30, 2019. Search terms included older adults, falls, medication classes, and hospitalizations among other related terms.

Synopsis: The review included a total of 14 articles (10 observational studies and 4 prospective intervention studies). High prevalence of FRID use (65%-93%) was seen in older adults with fall-related injury. Use of FRIDs continued to remain high at 1 month and 6 months follow-up after a fall. Antidepressants, sedative-hypnotics, opioids, and antipsychotics were the most commonly used FRIDs. Three randomized controlled trials showed no effect of reducing FRID use on reduction in falls. An outpatient clinic pre-post assessment study based on intervention by geriatrician and communication with prescribing physicians led to reduction in FRID use and falls.

Limitations of this review included high risk of bias in observational studies and unclear timeline definitions of interventions or outcome measurements in the intervention studies. In conclusion, there is a significant need for well-designed interventions targeted at reducing FRID use in conjunction with other risk factors to decrease the incidence of falls comprehensively. An aggressive approach directed toward patient education along with primary care communication may be the key to reducing FRID use in this population.

Bottom line: With limited evidence, there is a high prevalence of FRID use in older adults presenting with falls and no reduction in FRID use following the encounter.

Citation: Hart LA et al. Use of fall risk-increasing drugs around a fall-related injury in older adults: A systematic review. J Am Geriatr Soc. 2020 Feb 17. doi: 10.1111/jgs.16369.

Dr. Yarra is a hospitalist and assistant professor of medicine at UK HealthCare, Lexington, Ky.

  • 1

    High prevalence of Fall Risk–Increasing Drugs in older adults after falls

    September 2, 2021

  • Pfizer starts dosing patients in oral COVID-19 drug trial

    September 2, 2021

  • Breakthrough infections twice as likely to be asymptomatic

    September 1, 2021

  • Another COVID-19 patient to get ivermectin after court order

    September 1, 2021

  • COVID-clogged ICUs ‘terrify’ those with chronic or emergency illness

    September 1, 2021

  • Study calls higher surgery costs at NCI centers into question

    September 1, 2021

  • 1

    Limited evidence for interventions to reduce post-op pulmonary complications

    September 1, 2021

  • 1

    Two swings, two misses with colchicine, Vascepa in COVID-19

    September 1, 2021

  • 1

    ‘Deeper dive’ into opioid overdose deaths during COVID pandemic

    September 1, 2021

  • 1

    Children and COVID: Weekly cases top 200,000, vaccinations down

    August 31, 2021

1 … 119 120 121 122 123 … 977
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences